What if you'd held IMUX?
A $1,000 investment in Immunic, Inc. (IMUX) at the month-end close of 2014-04 would be worth $3.16 at the close of 2026-08 — -99.7% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $4,091.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2014
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2014 | $1,000 | — |
| 2015 | $462 | -53.8% |
| 2016 | $174 | -62.2% |
| 2017 | $239 | +36.8% |
| 2018 | $7.46 | -96.9% |
| 2019 | $9.73 | +30.4% |
| 2020 | $15.33 | +57.6% |
| 2021 | $9.60 | -37.4% |
| 2022 | $1.40 | -85.4% |
| 2023 | $1.50 | +7.1% |
| 2024 | $1.00 | -33.3% |
| 2025 | $0.54 | -46.6% |
| 2026 | $1.65 | +208.1% |
Best and worst month-end to buy
The best single month-end close to have bought IMUX was 2025-12 ($5.34): $1,000 then is $3,081 today. The worst was 2014-06 ($10,896): $1,000 then is $1.51.
FAQ
What would $1,000 in IMUX be worth today?
A $1,000 investment in Immunic, Inc. (IMUX) at the start of 2014 would be worth about $3.16 today, a total return of -99.7%. Dividends are reinvested in these figures.
What were the best and worst years for IMUX?
Immunic, Inc. (IMUX)'s strongest calendar year since 2014 was 2026, a +208.1% return — $1,000 held through that year became about $3,081 by year-end. Its weakest year was 2018, at -96.9%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in IMUX have grown?
Investing $100 at the end of every month since 2014-04 would have grown to about $7,603 on $14,900 invested.
Did IMUX beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $4,091. IMUX trailed the S&P 500 by +99.9% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Immunic, Inc. (IMUX) historical total-return data from 2014-04 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.